Recently, scientists at Nanyang Technological University (NTU) Medical School in Singapore have developed a device that allows physicians to find out whether inflammation exists in diabetic patients in minutes. Diagnostics currently in use are routinely performed on whole blood counts, which can require nearly hours of waiting time.
New test kit method is simple and low cost
Instead of collecting a patient's blood with the original treatment, the new test kit requires only a drop of blood to test whether patients with diabetes have an inflammatory response due to abnormal immune cell activation.
The traditional inspection methods currently used require the manual separation of a variety of blood cells, which is time-consuming and laborious, and these efforts are fully automated on new test kits.
In addition, the test suite produced in Singapore may also reduce the price of testing. The cost of this operation is less than one dollar.
Nanyang Polytechnic University School of Medicine Professor Boehm and HOU hand-held joint design of the new diabetes inflammation test equipment
Hou Han Wei, inventor of key chipset
Hou Han Wei, a senior researcher at Lee Kwang-Qian Medical School of Nanyang Technological University, has designed the key chip of the test suite. Dr. HOU explained, "By designing very small channels on the chip, we can separate blood cells of different sizes, just like the blood centrifuge and its."
Leukocytes are a key component of the immune system that makes up our body and is also one of the important types of neutrophils, the first line of defense in human infection or inflammation. "The analysis of these isolated neutrophils can help determine the incidence of inflammation and determine if the risk of contracting this diabetes is increased." Dr. HOU's new equipment and findings were published earlier this year In the "scientific report periodical". The Science Report is a comprehensive scientific journal of nature under the banner of Nature.
Nanyang Technological University under the microscope to demonstrate how the new type of diabetic inflammation test equipment classification of specific white blood cells. Source: Nanyang Technological University
Dr. HOU is the recipient of the 2014 Postdoctoral Research Fund at Lee Kwang Qian Medical School. In the near future, he hopes, clinicians can provide more targeted treatments for accurately adjusting the correct drug combination for all diabetic patients.
Metal can,Tin can,Tin packaging,Tin box,Tinplate can
Jiangsu Fast Pack Co., Ltd , https://www.fastmetalpack.com